STAAR Surgical Company Overview
Pro stress-test →STAAR Surgical designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company has been dedicated solely to ophthalmic surgery for over 30 years and is the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction.
Strategic Profile
Pro stress-test →The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. More than 4,000,000 ICLs have been sold to date and STAAR has over 900 employees and markets lenses in over 75 countries.
Competitive Landscape
Pro stress-test →STAAR competes primarily with Alcon (global eye care leader) and LASIK/vision correction alternatives. The company's strength lies in its proprietary ICL technology and specialized focus on implantable refractive lenses, differentiating it from broader ophthalmology device makers.
Industry Context
STAAR Surgical Company operates in Medical Devices - Ophthalmic Surgery.
Key facts
Founded: 1982 · Headquarters: Lake Forest, California, United States · Employees: 900-1,157 · Revenue: $313.9M · Market cap: $1.3B